ATE327749T1 - Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie - Google Patents

Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie

Info

Publication number
ATE327749T1
ATE327749T1 AT03777932T AT03777932T ATE327749T1 AT E327749 T1 ATE327749 T1 AT E327749T1 AT 03777932 T AT03777932 T AT 03777932T AT 03777932 T AT03777932 T AT 03777932T AT E327749 T1 ATE327749 T1 AT E327749T1
Authority
AT
Austria
Prior art keywords
prophylaxis
treatment
hypoestoxides
hyperlipidemia
agonists
Prior art date
Application number
AT03777932T
Other languages
English (en)
Inventor
Emeka J Nchekwube
Emmanuel A Ojo-Amaize
Howard B Cottam
Original Assignee
Paraquest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paraquest Inc filed Critical Paraquest Inc
Application granted granted Critical
Publication of ATE327749T1 publication Critical patent/ATE327749T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03777932T 2002-10-28 2003-10-28 Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie ATE327749T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42153302P 2002-10-28 2002-10-28

Publications (1)

Publication Number Publication Date
ATE327749T1 true ATE327749T1 (de) 2006-06-15

Family

ID=32230237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03777932T ATE327749T1 (de) 2002-10-28 2003-10-28 Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie

Country Status (9)

Country Link
US (1) US20040087553A1 (de)
EP (1) EP1558240B1 (de)
CN (1) CN1731992A (de)
AT (1) ATE327749T1 (de)
AU (1) AU2003286721A1 (de)
BR (1) BR0306632A (de)
CA (1) CA2509834A1 (de)
DE (1) DE60305727T2 (de)
WO (1) WO2004039362A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229979B2 (en) * 2003-06-23 2007-06-12 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
US20060094695A1 (en) * 2004-11-02 2006-05-04 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use in the prophylaxis and treatment of obesity
WO2016144441A1 (en) * 2015-03-09 2016-09-15 Immune Modulation, Inc. Hypoestoxide, derivatives, related compounds, and agonists thereof for treatment or prevention of neurodegenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US6001871A (en) * 1998-01-15 1999-12-14 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as antiviral agents
US5994328A (en) * 1998-01-14 1999-11-30 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as anticancer agents
US5801193A (en) * 1997-04-15 1998-09-01 Immune Modulation, Inc. Compositions and methods for immunosuppressing
US6242484B1 (en) * 1999-07-06 2001-06-05 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use of antiparasitic agents

Also Published As

Publication number Publication date
DE60305727T2 (de) 2007-05-31
CA2509834A1 (en) 2004-05-13
WO2004039362A2 (en) 2004-05-13
WO2004039362A3 (en) 2004-07-08
US20040087553A1 (en) 2004-05-06
EP1558240B1 (de) 2006-05-31
CN1731992A (zh) 2006-02-08
AU2003286721A1 (en) 2004-05-25
BR0306632A (pt) 2004-09-28
EP1558240A2 (de) 2005-08-03
DE60305727D1 (de) 2006-07-06

Similar Documents

Publication Publication Date Title
SE0203713D0 (sv) Novel compounds
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
ATE408601T1 (de) Fredericamycin-derivate
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
NO955256L (no) Fenylheterosykluser som syklooksygenase-2-inhibitorer
DE60118003D1 (de) Harnstoffderivate und ihre verwendung
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
TW200603823A (en) Novel use of peptide compounds for treating essential tremor and other tremor syndromes
BRPI0410727A (pt) composto, composição farmacêutica, e, uso de um composto
HRP20050103B1 (hr) N-aril supstituirani bifenilkarboksamidi kao inhibitori sekrecije apolipoproteina b
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
ATE400564T1 (de) Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
MXPA05013226A (es) Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas.
EA200601120A1 (ru) N-арилпиперидинзамещённые бифинилкарбоксамиды в качестве ингибиторов аполипопротеина в
ES2345882T3 (es) Nuevos compuestos y su uso como moduladores de ppar.
ATE443044T1 (de) Tace inhibitoren
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
DE60305727D1 (de) Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie
EA200600439A1 (ru) 4- ((феноксиалкил)тио) феноксиуксусные кислоты и аналоги
SE0301883D0 (sv) New use II

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties